Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00413
|
|||||
Drug Name |
Atazanavir
|
|||||
Synonyms |
(2S)-N-(3-{[(2S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoylamino][(4-(2-pyridyl)phenyl)methyl]amino}(1S,2S)-2-hydroxy-1-benzylpropyl)-2-(methoxycarbonylamino)-3,3-dimethylbutanamide; (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER; ATV; ATZ; Atazanavir (INN); Atazanavir [INN:BAN];BMS-232632; Atazanavirum; BMS 232632; CGP 73547; CGP-73547; DR7; Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate; Latazanavir; METHYL [(1S,4S,5S,10S)-4-BENZYL-1,10-DI-TERT-BUTYL-5-HYDROXY-2,9,12-TRIOXO-7-(4-PYRIDIN-2-YLBENZYL)-13-OXA-3,7,8,11-TETRAAZATETRADEC-1-YL]CARBAMATE; Methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate; Reyataz; Reyataz (TN); Reyataz(TM) (*1:1 sulfate*); Reyataz, BMS-232632, Atazanavir; Zrivada
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Anti-HIV Agents
|
|||||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C38H52N6O7
|
|||||
Canonical SMILES |
CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC
|
|||||
InChI |
InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1
|
|||||
InChIKey |
AXRYRYVKAWYZBR-GASGPIRDSA-N
|
|||||
CAS Number |
CAS 198904-31-3
|
|||||
Pharmaceutical Properties | Molecular Weight | 704.9 | Topological Polar Surface Area | 171 | ||
Heavy Atom Count | 51 | Rotatable Bond Count | 18 | |||
Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 9 | |||
XLogP |
5.6
|
|||||
PubChem CID | ||||||
PubChem SID |
10249838
,103338831
,104418454
,124757264
,124894049
,125164068
,125267482
,126649083
,126665840
,126731250
,127338999
,127339000
,127474087
,134337995
,134339780
,135105507
,135692446
,137004575
,142410398
,143496681
,144206632
,14715932
,14766361
,14790731
,15047322
,152234924
,152344127
,160647610
,17436380
,24276961
,46225140
,46393831
,46508504
,46512956
,49831615
,50067727
,50070909
,50780515
,51091799
,53801241
,57346722
,621982
,85177037
,85177040
,85177051
,85177056
,87225781
,92308998
,92729699
,99437162
|
|||||
ChEBI ID |
ChEBI:37924
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.